IRENE
COZAR CASTELLANO
PROFESORES TITULARES DE UNIVERSIDAD
Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (13)
2023
-
Insulin-degrading enzyme (IDE) as a modulator of microglial phenotypes in the context of Alzheimer’s disease and brain aging
Journal of Neuroinflammation, Vol. 20, Núm. 1
-
Pharmacological activation of insulin-degrading enzyme improves insulin secretion and glucose tolerance in diet-induced obese mice
Diabetes, Obesity and Metabolism, Vol. 25, Núm. 11, pp. 3268-3278
2022
-
Evolutionary Origin of Insulin-Degrading Enzyme and Its Subcellular Localization and Secretion Mechanism: A Study in Microglial Cells
Cells, Vol. 11, Núm. 2
-
Insulin-degrading enzyme ablation in mouse pancreatic alpha cells triggers cell proliferation, hyperplasia and glucagon secretion dysregulation
Diabetologia, Vol. 65, Núm. 8, pp. 1375-1389
-
Primary Cilia in Pancreatic β- and α-Cells: Time to Revisit the Role of Insulin-Degrading Enzyme
Frontiers in Endocrinology, Vol. 13
2021
-
Effects of fasting and feeding on transcriptional and posttranscriptional regulation of insulin‐degrading enzyme in mice
Cells, Vol. 10, Núm. 9
-
Modulation of insulin sensitivity by insulin-degrading enzyme
Biomedicines, Vol. 9, Núm. 1, pp. 1-38
-
miR-126 contributes to the epigenetic signature of diabetic vascular smooth muscle and enhances antirestenosis effects of Kv1.3 blockers
Molecular Metabolism, Vol. 53
2020
-
Hepatic insulin-degrading enzyme regulates glucose and insulin homeostasis in diet-induced obese mice
Metabolism: Clinical and Experimental, Vol. 113
-
Intestinal fructose and glucose metabolism in health and disease
Nutrients, Vol. 12, Núm. 1
-
Modulation of Glial Responses by Furanocembranolides: Leptolide Diminishes Microglial Inflammation in Vitro and Ameliorates Gliosis In Vivo in a Mouse Model of Obesity and Insulin Resistance
Marine drugs, Vol. 18, Núm. 8
2019
-
Pancreatic β-cell-specific deletion of insulin-degrading enzyme leads to dysregulated insulin secretion and β-cell functional immaturity
American journal of physiology. Endocrinology and metabolism, Vol. 317, Núm. 5, pp. E805-E819